Numerous studies have investigated the relationship between redox proteins, including the Trx system proteins, and clinicopathological features and survival in patients with various cancers, including ovarian, breast, gastroesophageal, colorectal, and brain cancers [25,26,27,28,29,30,31]. This evidence concerns the gene TXN and cancer.